Amount Raised
$60 Million
Round Type
Series A
LittletonBiotechnologyInvestors
Description
Nexo Therapeutics today emerged from stealth with a $60 million Series A financing led by founding investor Versant Ventures with participation from New Enterprise Associates and Cormorant Asset Management. The company also announced a multi-year strategic research collaboration with The University of Texas MD Anderson Cancer Center, the details of which are described in a separate announcement.
Quick answer
Nexo Therapeutics raised $60 Million in a Series A round, dated July 26, 2023. Investors: University Of Texas Md Anderson Cancer Center, Cormorant Asset Management, New Enterprise Associates and Versant Ventures. Nexo Therapeutics is based in Littleton, Colorado, United States.
- How much did Nexo Therapeutics raise?
- Nexo Therapeutics raised $60 Million in a Series A round on July 26, 2023.
- Who invested in Nexo Therapeutics?
- University Of Texas Md Anderson Cancer Center, Cormorant Asset Management, New Enterprise Associates and Versant Ventures are named as investors in this round.
- What does Nexo Therapeutics do?
- Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
- Where is Nexo Therapeutics based and how big is it?
- Nexo Therapeutics is based in Littleton, Colorado, United States. Fundz records about 20 employees.
- Who are the decision-makers at Nexo Therapeutics?
- Fundz holds 2 contacts at Nexo Therapeutics, including the Sr. Director, Head of Computational Chemistry and Informatics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Nexo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Deverra Therapeutics raised $2.4M (Seed) on September 8, 2023.
- Meta Materials raised $250K on September 8, 2023.
- ProMIS Neurosciences raised $20M (Post-IPO Equity) on September 8, 2023.
- Porosome Therapeutics raised $2.5M (Seed) on September 8, 2023.
- Grit Biotechnology raised $60M (Series B) on September 8, 2023.
- Tierra Biosciences raised $18M on September 8, 2023.
Who to call at Nexo Therapeutics, and when
A new round usually means Nexo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nexo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nexo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nexo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nexo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNexo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.